# Octapharma Plasma Inc – FDA Inspection, Feb 2, 2023

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e809e028-ce1e-48a6-ac9b-87d2d1c033a1
Source feed: FDA_Inspections

> FDA inspection 1196585 of Octapharma Plasma Inc, February 02, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1196585
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2023-02-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/sergio-e-delgado/5edfee62-05aa-44aa-9161-def8f31d3ea2)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/a51b21d1-afc2-470c-b51e-24e60bd96fc2

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d